PATENT CLAIM ANALYSIS

Application Number: 16059121
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).

Claim (Index 8):
The isolated nucleic acid of  claim 1 , wherein the third region is between the first codon of the exogenous mRNA and a position 1000 nucleotides upstream of the first codon.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.08
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14113118', '15098833', '13642719', '14445670', '15705909']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7780499744448415
- 35 USC 102 Novelty (BERT): 0.6993369177392087
- Combined Prediction Score: 0.7701786687742782
- Mean Citation Score: 539.9870999999998
- Max Citation Score: 791.0799599999997
- Similarity Product: 689.2903050316286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test